ADx logo

news and events

Novel biomarker will be presented at CTAD, San Diego

01/12/2016 News

A novel biomarker, phospho-threonine 231 tau (P-tau 231) is available now and could be of benefit for the development of a new generation of Alzheimer drugs.

Read More

ADx signs R&D agreement with Nipro Medical Corporation

12/10/2016 News

Belgium and Japan join forces against Alzheimer's disease.

Read More

ADx NeuroSciences announces capital increase

30/03/2016 News

Renewed investments ensure ADx'continued growth.

Read More